Matthew Sherman, MD

Children's National Hospital
Washington, DC, United States

Fellow

Disclosure information not submitted.

Presentation(s):

• 0512: Development of CARRA Biologic Consensus Treatment Plans for Management of Refractory Moderate Juvenile Dermatomyositis

  Saturday, November 12, 2022
  3:00 PM – 3:10 PM Eastern Time